InvestorsContact Us
    Pipeline

    A First-in-Class Platform
    for Bone Formation

    Oral Biolife is advancing a disciplined, platform-driven pipeline focused on restoring bone in indications where current therapies fail.

    Human
    Expansion

    Ambrilux™ Dental Gel

    Human

    Injectable, light-curable•Periodontal bone loss

    Preclinical
    Next: FIH 2026

    Peri-Implantitis Program

    Human

    Injectable, site-specific•Bone loss around dental implants

    Preclinical

    Craniofacial Program

    Human

    Configurable scaffold•Craniofacial bone defects

    Platform Expansion

    Orthopedic Program

    Human

    Load-bearing formulations•Orthopedic bone regeneration

    Platform Expansion

    All programs leverage Oral Biolife's core piezoelectric regenerative platform. Program timing and indication expansion are subject to clinical, regulatory, and strategic considerations.

    Partner With Us

    Interested in collaboration or investment opportunities?

    Get in Touch